Marybeth Dalessandro

Molecular Epidemiology of Methicillin-Resistant and Methicillin-Susceptible <i>Staphylococcus aureus</i> Isolates from Global Clinical Trials

Richard V. Goering, Ribhi M. Shawar, Nicole Scangarella et al. · Journal of Clinical Microbiology · 2008 · 115 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections

Karen O’Dwyer, Aaron Spivak, Karen Ingraham et al. · Antimicrobial Agents and Chemotherapy · 2014 · 98 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV

Charlotte-Paige Rolle, Mezgebe Berhe, Tulika Singh et al. · AIDS · 2021 · 64 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Retapamulin Ointment Twice Daily for 5 Days vs Oral Cephalexin Twice Daily for 10 Days for Empiric Treatment of Secondarily Infected Traumatic Lesions of the Skin

Almena Free, Eli M. Roth, Marybeth Dalessandro et al. · SKINmed Dermatology for the Clinician · 2006 · 44 citations

Pharmacy, Infectious Diseases, Antimicrobial Pharmacotherapy +7

Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness study

Cindy Garris, Maggie Czarnogorski, Marybeth Dalessandro et al. · Journal of the International AIDS Society · 2022 · 44 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +15